Only Optos ultra-widefield technology can capture a 200° view (or 82%) of the retina in a single, high resolution optomap® image in less than ½ second. optomap provides 3-in-1 Colour Depth Imaging™: colour, sensory (red free) and choroidal, along with autofluorescence imaging. A larger field of view of the retina uncovers more clinical information which facilitates the early detection, management and effective treatment of disorders and diseases such as retinal detachments and tears, glaucoma, diabetic retinopathy and age-related macular degeneration. It can also indicate evidence of non-eye or systemic diseases such as hypertension and certain cancers. 500+ published and ongoing clinical trials as well as thousands of customer case studies and testimonials support it’s long term value; optomap is the only clinically validated ultra-widefield imaging technology in the industry, therefore helping eyecare professionals save sight and save lives.